Kraig Biocraft Laboratories (KBLB) Shares Outstanding (Weighted Average) (2010 - 2025)

Kraig Biocraft Laboratories' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $1.1 billion for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 2.03% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $1.1 billion (up 2.03% YoY), while the FY2025 annual figure was $1.1 billion, up 2.03% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.1 billion for Q4 2025 at Kraig Biocraft Laboratories, down from $1.1 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.1 billion in Q3 2025 to a low of $855.1 million in Q1 2021.
• A 5-year average of $989.9 million and a median of $1.0 billion in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) increased 12.82% in 2022 and rose 0.3% in 2025, its largest moves.
• Kraig Biocraft Laboratories' Shares Outstanding (Weighted Average) stood at $877.6 million in 2021, then increased by 11.02% to $974.3 million in 2022, then increased by 6.04% to $1.0 billion in 2023, then climbed by 0.51% to $1.0 billion in 2024, then gained by 2.03% to $1.1 billion in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $1.1 billion, $1.1 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison